This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human Oncostatin M (OSM) DuoSet ELISA
catalog :
DY295
quantity :
1 Kit (for 15 Plates)
price :
850 USD
citations: 19
Reference
Louault K, Blavier L, Lee M, Kennedy R, Fernandez G, Pawel B, et al. Nuclear factor-κB activation by transforming growth factor-β1 drives tumour microenvironment-mediated drug resistance in neuroblastoma. Br J Cancer. 2024;131:90-100 pubmed publisher
Adir O, Sagi Assif O, Meshel T, Ben Menachem S, Pasmanik Chor M, Hoon D, et al. Heterogeneity in the Metastatic Microenvironment: JunB-Expressing Microglia Cells as Potential Drivers of Melanoma Brain Metastasis Progression. Cancers (Basel). 2023;15: pubmed publisher
Kleuskens M, Bek M, Al Halabi Y, Blokhuis B, Diks M, Haasnoot M, et al. Mast cells disrupt the function of the esophageal epithelial barrier. Mucosal Immunol. 2023;16:567-577 pubmed publisher
Nikanfar S, Hamdi K, Haiaty S, Samadi N, Shahnazi V, Fattahi A, et al. Oncostatin M and its receptor in women with polycystic ovary syndrome and association with assisted reproductive technology outcomes. Reprod Biol. 2022;22:100633 pubmed publisher
Jones M, Vanyo S, Ibraheem W, Maddi A, Visser M. Treponema denticola stimulates Oncostatin M cytokine release and de novo synthesis in neutrophils and macrophages. J Leukoc Biol. 2020;108:1527-1541 pubmed publisher
Parashar D, Geethadevi A, Aure M, Mishra J, George J, Chen C, et al. miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer. Cell Rep. 2019;29:4389-4406.e10 pubmed publisher
Tawara K, Bolin C, Koncinsky J, Kadaba S, Covert H, Sutherland C, et al. OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung. Breast Cancer Res. 2018;20:53 pubmed publisher
Shien K, Papadimitrakopoulou V, Ruder D, Behrens C, Shen L, Kalhor N, et al. JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung Cancer. Mol Cancer Ther. 2017;16:2234-2245 pubmed publisher
Kucia Tran J, Tulkki V, Smith S, Scarpini C, Hughes K, Araujo A, et al. Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial-mesenchymal transition and poor overall survival. Br J Cancer. 2016;115:212-22 pubmed publisher
Su C, Chiang Y, Huang C, Hsu C, Fong Y, Tang C. Osteopontin Promotes Oncostatin M Production in Human Osteoblasts: Implication of Rheumatoid Arthritis Therapy. J Immunol. 2015;195:3355-64 pubmed publisher
Chen C, Su C, Huang Y, Tsai C, Fuh L, Tang C. CCN1 induces oncostatin M production in osteoblasts via integrin-dependent signal pathways. PLoS ONE. 2014;9:e106632 pubmed publisher
Nicolaidou V, Wong M, Redpath A, Ersek A, Baban D, Williams L, et al. Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation. PLoS ONE. 2012;7:e39871 pubmed publisher
Hintzen C, Quaiser S, Pap T, Heinrich P, Hermanns H. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis. Arthritis Rheum. 2009;60:1932-43 pubmed publisher
Duluc D, Delneste Y, Tan F, Moles M, Grimaud L, Lenoir J, et al. Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood. 2007;110:4319-30 pubmed
Sugaya M, Fang L, Cardones A, Kakinuma T, Jaber S, Blauvelt A, et al. Oncostatin M enhances CCL21 expression by microvascular endothelial cells and increases the efficiency of dendritic cell trafficking to lymph nodes. J Immunol. 2006;177:7665-72 pubmed
Queen M, Ryan R, Holzer R, Keller Peck C, Jorcyk C. Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Res. 2005;65:8896-904 pubmed
López Karpovitch X, Barrales Benitez O, Flores M, Piedras J. Effect of azacytidine in the release of leukemia inhibitory factor, oncostatin m, interleukin (IL)-6, and IL-11 by mononuclear cells of patients with refractory anemia. Cytokine. 2002;20:154-62 pubmed
Suda T, Chida K, Todate A, Ide K, Asada K, Nakamura Y, et al. Oncostatin M production by human dendritic cells in response to bacterial products. Cytokine. 2002;17:335-40 pubmed
Savarese T, Campbell C, McQuain C, Mitchell K, Guardiani R, Quesenberry P, et al. Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas. Cytokine. 2002;17:324-34 pubmed
product information
master code :
DY295
SKU :
DY295
product name :
Human Oncostatin M (OSM) DuoSet ELISA
unit size :
1 Kit (for 15 Plates)
description :
The Human Oncostatin M (OSM) DuoSet ELISA from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human Oncostatin M/OSM.
target :
Oncostatin M/OSM
category :
ELISAs
species :
Human
gene symbol :
OSM
kit type :
Solid Phase Sandwich ELISA
assay length :
4 hours 40 minutes (after plate preparation)
elisaRange :
31.20 - 2000 pg/mL
top caption :
Human Oncostatin M/ OSM ELISA Standard Curve
applications :
ELISA
USD :
850 USD
alt names :
MGC20461, oncostatin M, oncostatin-M
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.